BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/15/2023 12:09:45 PM | Browse: 141 | Download: 558
 |
Received |
|
2023-03-08 03:47 |
|
Peer-Review Started |
|
2023-03-08 03:47 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-03-15 03:39 |
|
Revised |
|
2023-03-18 12:58 |
|
Second Decision |
|
2023-04-14 03:18 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-04-14 09:37 |
|
Articles in Press |
|
2023-04-14 09:37 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-06-02 01:12 |
|
Publish the Manuscript Online |
|
2023-06-15 12:09 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Treatment outcome analysis of bevacizumab combined with cyclophosphamide and oxaliplatin in advanced pseudomyxoma peritonei
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ying Zhang, Xin Zhao, Chao Gao, Lin-Yu Lin and Yan Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Beijing Municipal Administration of Hospitals’ Ascent Plan |
DFL20180701 |
| Beijing Municipal Grant for Medical Talents Group on Peritoneal Surface Oncology |
2017400003235J007 |
|
| Corresponding Author |
Yan Li, MD, PhD, Doctor, Doctor, Surgical Oncologist, Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tieyi Road, Yangfangdian Street, Haidian District, Beijing 100038, China. liyansd2@mail.ccmu.edu.cn |
| Key Words |
Peritoneal pseudomyxoma; Bevacizumab; Oxaliplatin; Cyclophosphamide |
| Core Tip |
For systemic chemotherapy of advanced pseudomyxoma peritonei (PMP), there are currently few studies and insufficient evidence. In this study, the bevacizumab combined with cyclophosphamide and oxaliplatin regimen was used for advanced PMP for the first time. The scheme used in this study was based on clinical experience and had achieved good results. |
| Publish Date |
2023-06-15 12:09 |
| Citation |
Zhang Y, Zhao X, Gao C, Lin LY, Li Y. Treatment outcome analysis of bevacizumab combined with cyclophosphamide and oxaliplatin in advanced pseudomyxoma peritonei. World J Gastrointest Surg 2023; 15(6): 1149-1158 |
| URL |
https://www.wjgnet.com/1948-9366/full/v15/i6/1149.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v15.i6.1149 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
